Piper Sandler Boosts Celsius (NASDAQ:CELH) Price Target to $69.00

Key Points

• Piper Sandler has raised its price target for Celsius (NASDAQ:CELH) from $60 to $69, indicating a potential upside of 24.42% from its current price.
• Despite a recent 5.0% decline in share price, Celsius reported an earnings per share (EPS) of $0.47, significantly beating the consensus estimate by $0.24.
• Seventeen analysts have rated Celsius stock with a "Buy" rating and one has given it a "Sell" rating, reflecting strong market confidence in the company's performance.

Celsius (NASDAQ:CELH - Get Free Report) had its price objective increased by analysts at Piper Sandler from $60.00 to $69.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an "overweight" rating on the stock. Piper Sandler's price target would suggest a potential upside of 24.42% from the company's current price.

A number of other brokerages also recently issued reports on CELH. Wells Fargo & Company raised their price target on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Citigroup reissued a "buy" rating on shares of Celsius in a report on Sunday, August 31st. Maxim Group boosted their target price on shares of Celsius from $50.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Wall Street Zen lowered Celsius from a "buy" rating to a "hold" rating in a report on Sunday, August 17th. Finally, Stephens reaffirmed an "overweight" rating on shares of Celsius in a research note on Monday, August 11th. Seventeen equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $61.42.

Celsius Stock Down 5.0%

Shares of CELH traded down $2.91 during trading hours on Monday, reaching $55.46. 4,495,756 shares of the stock traded hands, compared to its average volume of 8,045,608. Celsius has a 52 week low of $21.10 and a 52 week high of $63.50. The stock has a fifty day simple moving average of $51.32 and a 200 day simple moving average of $41.24. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $14.31 billion, a price-to-earnings ratio of 149.47, a PEG ratio of 1.32 and a beta of 1.33.

Celsius (NASDAQ:CELH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The company had revenue of $739.30 million for the quarter, compared to analyst estimates of $632.13 million. The firm's quarterly revenue was up 83.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.28 EPS. On average, equities analysts forecast that Celsius will post 0.89 EPS for the current year.

Insiders Place Their Bets

In other Celsius news, CFO Jarrod Langhans sold 5,000 shares of the company's stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $60.00, for a total transaction of $300,000.00. Following the sale, the chief financial officer owned 104,227 shares in the company, valued at $6,253,620. This represents a 4.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Deborah Desantis sold 100,000 shares of the business's stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the transaction, the insider owned 17,717,770 shares of the company's stock, valued at approximately $841,594,075. The trade was a 0.56% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,123,641 shares of company stock valued at $52,998,580. Corporate insiders own 2.20% of the company's stock.

Institutional Investors Weigh In On Celsius

Hedge funds have recently modified their holdings of the stock. Westside Investment Management Inc. acquired a new position in Celsius during the first quarter worth about $32,000. Summit Securities Group LLC acquired a new stake in shares of Celsius during the 1st quarter valued at approximately $34,000. MassMutual Private Wealth & Trust FSB boosted its holdings in Celsius by 255.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after purchasing an additional 750 shares during the period. Hantz Financial Services Inc. increased its stake in Celsius by 1,476.0% during the second quarter. Hantz Financial Services Inc. now owns 788 shares of the company's stock valued at $37,000 after purchasing an additional 738 shares during the last quarter. Finally, UMB Bank n.a. grew its position in shares of Celsius by 145.0% during the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock valued at $51,000 after buying an additional 844 shares during the last quarter. 60.95% of the stock is owned by institutional investors and hedge funds.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.